Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS).
| Publicado en: | Journal of Cardiac Failure Vol. 32; no. 5; pp. 877 - 888 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
W B Saunders
May2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=193805057&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 193805057 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10719164 DOP jtl: Journal of Cardiac Failure issn: 10719164 maglogo: N pubinfo: dt: May2026 vid: 32 iid: 5 pid: 1351 pub: W B Saunders place: Philadelphia, Pennsylvania artinfo: ui: 193805057 10.1016/j.cardfail.2026.03.010 193805057 ppf: 877 ppct: 11 formats: tig: atl: Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS). aug: au: ROSENBAUM, ANDREW N. WAGLE, ANJALI MEUTH, COURTNEY L. WANG, SHELDON PAOLINI, JOHN F. BRATCHER, MELANIE A. CHAREONTHAITAWEE, PANITHAYA GILOTRA, NISHA A. affil: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|